Personnel Moves Archives - Page 7 of 42

Cardio Flow announces first commercial FreedomFlow uses, appoints new COO

[Image courtesy of Cardio Flow]Cardio Flow today announced the successful completion of the first commercial cases for its FreedomFlow orbital atherectomy platform.

FreedomFlow, a device designed to treat peripheral artery disease (PAD), received FDA clearance earlier this month. Dr. Craig Walker, Dr. Pradeep Naier and Dr. McCall Walker performed the initial U.S. cases with the device. The procedures took place at the Cardiovascular Institute of the South (CIS) at the Terrebonne General Health System in Houma, Louisiana.

Cardio Flow designed FreedomFlow with a modern mechanism of action to clear plaque blockages in the arteries of the legs. The design uses the physics of angular momentum to create a spiral geometry. It puts five diamond-coated spheres in simultaneous contact with the vessel wall. The diamond-coated tip also helps ease the driveshaft through tight blockages.

The first patient treated at Terrebonne had complex arterial anatomy and multiple bl…

Neuromod tech developer Cognito Therapeutics has a new CCO

Christian Howell. [Image courtesy of Cognito Therapeutics]Cognito Therapeutics announced today that it named Christian Howell as its new chief commercial officer (CCO).

Cambridge, Massachusetts–based Cognito Therapeutics develops a non-invasive neuromodulation device that delivers proprietary gamma frequency light and sound stimulation. The company’s investigational device is intended to treat Alzheimer’s disease.

Howell joins the company with more than 20 years of medical device experience. His past includes responsibilities in business development, commercial leadership, product management, market development and strategy.

Before joining Cognito, Howell served as SVP and GM of Aetion’s medical device and diagnostic group. Prior to that, Howell had a nearly 15-year stint at Medtronic, leading its value-based healthcare partnerships organization. He also held P&L responsibility for Medtronic’s integrated health solutions program.

<…

Johnson & Johnson MedTech Chair Ashley McEvoy announces resignation

Former Johnson & Johnson MedTech Worldwide Chair Ashley McEvoy [Photo courtesy of Johnson & Johnson]Johnson & Johnson (NYSE: JNJ) + MedTech Worldwide Chair Ashley McEvoy plans to leave the world’s second-largest medical device manufacturer, she and J&J said today.

After 27 years with J&J — starting in consumer products and rising to the position of EVP and head of the company’s medical devices group — McEvoy gave her notice on Friday “to pursue new opportunities,” she said today.

McEvoy will stay on into the company’s first quarter, which starts in January 2024.

Medical Design & Outsourcing: Ashley McEvoy joins J&J’s top-paid executives

New Brunswick, New Jersey-based J&J has already appointed Tim Schmid, most recently J&J MedTech Asia Pacific (APAC) company group chair, as a J&J EVP and J&J MedTech’s new worldwide chair.

…

Ambu names new chief financial officer

Ambu today announced it appointed Henrik Skak Bender as chief financial officer, effective January 1, 2024.

Bender will replace Thomas Frederik Schmidt, who intends to step down on December 31. Under Schmidt’s leadership, the company said in a news release it returned to positive free cash flow and it has taken the first steps toward strong profitable growth. Ambu plans to focus on accelerating growth and improving profitability with Bender’s appointment.

“In the progression of Ambu’s Zoom In strategy, I have, together with the Board, decided to bring in a new leadership profile to execute on the next phase of Ambu’s transformation and growth journey. I am convinced that Henrik is the right profile for the CFO role at Ambu, as he brings strategic and operational experience from global companies, as well as the medical device industry. On behalf of myself and the Board, I want to thank Thomas for his contributions to Ambu, and I wish him the be…

Silk Road Medical CEO announces retirement

[Image courtesy of Silk Road Medical]Silk Road Medical (Nasdaq:SILK) today announced that CEO Erica Rogers plans to retire from the company.

Rogers will formally retire once the succession process is completed. The Sunnyvale, California-based company is working with executive search firm Spencer Stuart to find a replacement CEO.

“I’d like to thank Erica for her tremendous contributions to Silk Road over the last 11 years. Erica has been integral in leading and expanding the company’s strong operational infrastructure and commercial enterprise and driving a significant expansion of the use of Transcarotid Artery Revascularization (TCAR) and its impact on patients. She also has created an enduring, mission-focused culture at Silk Road, setting the Company apart,” Silk Road Chair Jack Lasersohn said in a news release. “The Silk Road Medical senior leadership team and Board of Directors are well-prepared for Erica’s transition. We plan to work closely together to ensu…

Integer promotes new chief financial officer from within

[Image from Diron Smith’s LinkedIn]Integer announced today that it appointed Diron Smith as executive vice president and chief financial officer, effectively immediately.

Smith has more than 30 years of extensive experience in global financial leadership roles at public companies, including Tiffany & Co and GE, and has served as Integer’s interim CFO since May 2023.

“Throughout his time at Integer, Diron has demonstrated the financial expertise and leadership capabilities necessary to lead our Finance organization and drive continuous improvements throughout the company,” Integer President and CEO Joe Dziedzic said in a news release. “His deep manufacturing and supply chain experience, candid nature, collaborative style and consistent pursuit of excellence make him the ideal candidate to help Integer advance our strategy and achieve our growth goals.”

Before becoming Integer’s VP of financial planning and analysis in August 2021, Smith…

LivaNova adds former NuVasive CEO to its board

New LivaNova board director J. Christopher Barry. [Image from NuVasive]LivaNova (Nasdaq: LIVN) + announced today that it appointed J. Christopher Barry as a new board director.

Barry’s appointment becomes effective today and he joins the board’s Audit and Compliance Committee. In turn, Andrea Saia intends to retire from the board on Dec. 31, 2023. Saia initially joined the board of the London-based medtech company as a director in 2016.

With the changes, the LivaNova board will include 10 directors until Saia’s retirement at the end of the year.

“The LivaNova board of directors is pleased to welcome Chris Barry,” said Bill Kozy, interim CEO and chair of LivaNova. “Chris has spent his career in the medical technology industry, and we look forward to adding his commercial expertise and ability to drive long-term growth to the board. Additionally, on behalf of the entire board, I’d like to thank Andr…

Medtronic has a new president of its Neuromodulation business

Paolo Di Vincenzo. [Image courtesy of Medtronic]Medtronic (NYSE: MDT) + announced today that it appointed Paolo Di Vincenzo as the president of its Neuromodulation business.

Di Vincenzo’s appointment at Medtronic goes into effect on Oct. 30. In his new role, he holds responsibilities for the overall strategic direction of the company’s neuromodulation business and day-to-day operations.

Neuromodulation is part of Medtronic’s Neurosciences portfolio, comprised of Pain Interventions and Brain Modulation. The unit engineers innovative therapies and technologies to help patients relieve pain, restore function and reclaim movement.

Di Vincenzo joins Medtronic from Smith+Nephew, where he served as SVP and GM of U.S. advanced wound management. Over nine years at the orthopedic giant, he also served in global marketing and leadership roles.

Before Smith+Nephew, Di Vincenzo held a number of marketin…

Insulet CFO departs for same post at 3M’s Health Care spinoff

Wayde McMillan. [Image from Insulet]Insulet (Nasdaq: PODD) + announced today that Wayde McMillan decided to leave his role as EVP, CFO and treasurer.

McMillan’s departure goes into effect on Oct. 20, 2023. He intends to join 3M as CFO of its Health Care business, which the company expects to spin off late this year or early next year.

President and CEO Jim Hollingshead called McMillan “a trusted partner and an excellent leader” of the company’s global finance team. He said McMillan helped to advance Insulet’s mission of improving the lives of people with diabetes.

“Wayde has helped make our company stronger and more resilient, ensuring we have the capabilities and financial strength to capitalize on the tremendous long-term growth opportunities Insulet is pursuing,” Hollingshead said in a news release. “On behalf of the board and our entire team, I thank Wayde for his…

Baxter picks a foodservice industry veteran as its new CFO

New Baxter CFO Joel Grade. [Image from Joel Grade on LinkedIn]Baxter (NYSE: BAX) + announced today that it appointed Joel Grade as EVP and chief financial officer (CFO).

Grade joins after more than two decades in financial roles in the food services industry. He succeeds Jay Saccaro, who departed for the same role at GE HealthCare in May. Saccaro spent 21 years at Baxter, with the last eight coming in the CFO capacity.

Reporting to Chair, President and CEO José (Joe) E. Almeida, Grade’s appointment goes into effect on Oct. 18, 2023. Brian Stevens, who served as interim CFO after Saccaro’s departure, will transition to his previous role as SVP, chief accounting officer and controller.

“Joel is a seasoned global financial executive with decades of deep operational and broad business experience as well as a proven record of results-driven impact,” said Almeida. “I am confident we will benefit from Joel’s …

Augmedics taps former Medtronic AI expert as new VP of R&D

Augmedics announced today that it appointed former Medtronic leader Dr. Tal Davidson as its VP of research & development.

Davidson most recently served as artificial intelligence (AI) research director site lead for Medtronic’s Visionsense. The medtech giant’s R&D site leads the development of intraoperative visualization and AI opportunities in minimally invasive surgery.

News of Davidson’s appointment comes after Augmedics recently acquired digital health assets from Surgalign and Holo Surgical. Augmedics won a competitive auction for the digital health assets with a cash purchase price of $900,000. The acquisition strengthened the company’s augmented reality (AR) and AI portfolio.

“The future of spine navigation exists at the intersection of best-in-class advanced visualization and decision support,” said Augmedics president & CEO Kevin Hykes. “Tal’s multidisciplinary leadership in intraoperative imaging & artif…

Ypsomed has a new CFO, board member

Samuel Künzli

Ypsomed announced today that it selected Samuel Künzli to take over the company’s chief financial officer (CFO) position.

Niklaus Ramseier elected to hand over the reins to the CFO position after more than 20 years in the post. The transition begins on March 31, 2024, with Ramseier remaining available to the drug delivery device maker for strategic projects. Künzli begins as CFO on April 1, 2024.

Get the full story at our sister site, Drug Delivery Business News.